ARTICLE | Company News
Hetero Drugs sales and marketing update
July 11, 2016 7:00 AM UTC
Hetero launched Cizumab, a biosimilar of Avastin bevacizumab, in India to treat metastatic colorectal cancer (mCRC). Hetero said the maximum retail price is Rs28,450 ($418.22) for a 100 mg vial and R...